Journal article
WTX mutations can occur both early and late in the pathogenesis of Wilms tumour
R Fukuzawa, SK Holman, CW Chow, R Savarirayan, AE Reeve, SP Robertson
Journal of Medical Genetics | Published : 2010
Abstract
Background: Somatic mutations in the X-linked tumour suppressor gene WTX have been observed in 6- 30% of sporadic cases of Wilms tumour. Germline mutations in the same gene cause the sclerosing skeletal dysplasia, osteopathia striata congenita with cranial sclerosis (OSCS). No evidence points towards a susceptibility to the development of tumours in individuals with OSCS, suggesting that there are unrecognised additional determinants that influence the phenotypic outcome associated with germline mutations in WTX. One explanation may be that a somatic mutation in WTX may need to occur late in tumour development to contribute to tumourigenesis. Methods: Here a panel of four sporadic Wilms tumo..
View full abstractGrants
Funding Acknowledgements
[ "This work is supported by Health Research Council of New Zealand, The Child Health Research Foundation of New Zealand and Lotteries Health New Zealand.", "Lotteries Health New Zealand, Health Research Council of New Zealand." ]